Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s disease despite improving bio ...

Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

Norwegian patients and researchers at Akershus University Hospital and Oslo University Hospital have taken part in two large ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and protection from dementia may soon be added to the list. "But whether ...

Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...

(CN) — An analysis of nearly 1.7 million patient records suggests that semaglutide — the active ingredient in popular diabetes and weight loss medications like Ozempic and Wegovy — may significantly ...

Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are ...

Weight-loss drugs like Ozempic and Mounjaro are so prevalent that 1 in 5 adults in the United States report taking these drugs for obesity. This class of drugs, known as glucagon-like peptide-1 ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and ...

Dozens of breakthrough drug trials, including one using the main ingredient in weight-loss jabs, offer patients “hope” for the treatment and prevention of dementia and Alzheimer’s disease. Some 138 ...

New research highlights two crucial, preventable dementia risk factors beyond memory loss: high "bad" cholesterol in mid-life ...